Spire Wealth Management Vertex Pharmaceuticals Inc Transaction History

Spire Wealth Management

$2.95 Billion
Q3 2024

A detailed history of Spire Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Spire Wealth Management holds 18,723 shares of VRTX stock, worth $8.7 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

18,723

Previous 19,754 5.22%

Holding current value

$8.7 Million

Previous $9.26 Million 5.96%

% of portfolio

0.3%

Previous 0.33%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$460.0 - $505.78 $474,260 - $521,459	-1,031 Reduced 5.22%	18,723 $8.71 Million
Q2 2024 Jul 31, 2024	SELL	$392.81 - $485.53 $118,235 - $146,144	-301 Reduced 1.5%	19,754 $9.26 Million
Q1 2024 Apr 24, 2024	SELL	$407.69 - $446.08 $242,983 - $265,863	-596 Reduced 2.89%	20,055 $8.38 Million
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $1.47 Million - $1.76 Million	4,274 Added 26.1%	20,651 $8.4 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $2.3 Million - $2.46 Million	-6,796 Reduced 29.33%	16,377 $5.69 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $500,242 - $559,888	-1,591 Reduced 6.42%	23,173 $8.15 Million
Q1 2023 May 09, 2023	BUY	$283.23 - $323.1 $1.04 Million - $1.18 Million	3,664 Added 17.36%	24,764 $7.8 Million
Q4 2022 Feb 03, 2023	SELL	$285.76 - $321.48 $193,173 - $217,320	-676 Reduced 3.1%	21,100 $6.09 Million
Q3 2022 Nov 07, 2022	SELL	$273.83 - $305.53 $1.44 Million - $1.61 Million	-5,276 Reduced 19.5%	21,776 $6.31 Million
Q2 2022 Jul 22, 2022	SELL	$234.96 - $292.55 $2.59 Million - $3.22 Million	-11,007 Reduced 28.92%	27,052 $7.62 Million
Q1 2022 Apr 18, 2022	BUY	$221.42 - $260.97 $7.84 Million - $9.24 Million	35,416 Added 1339.99%	38,059 $9.94 Million
Q4 2021 Jan 14, 2022	BUY	$177.01 - $223.45 $305,696 - $385,898	1,727 Added 188.54%	2,643 $580,000
Q3 2021 Oct 22, 2021	SELL	$181.39 - $202.99 $81,625 - $91,345	-450 Reduced 32.94%	916 $166,000
Q2 2021 Jul 26, 2021	SELL	$187.49 - $221.1 $630,341 - $743,338	-3,362 Reduced 71.11%	1,366 $275,000
Q1 2021 May 21, 2021	BUY	$207.02 - $241.31 $978,790 - $1.14 Million	4,728 New	4,728 $1.02 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Vertex Pharmaceuticals Inc Transaction History